Tag: major depressive disorder
Major Depressive Disorder, Suicides, and the Role of Dimensional Psychiatry for Triaging in Primary Care Settings: A Case Series Retroanalysis
by Atmaram Yarlagadda, MD; Adrian R. Johnson, LCSW, MSW; Cheyenne M. Bickerstaff, BS; Joseph R. Yancey, MD, MBA; Samuel L. Preston, DO; Liquori L. Etheridge, LCSW; Michelle Maddalozzo, LCSW; Samuel Ochinang, LCSW; Rosemary A. Jackson, DNP, PMHNP-BC; and Anita H. Clayton, MD Dr. Yarlagadda is Installation Director of Psychological Health at McDonald Army Health Center in Fort Eustis, […]
The Depression Inventory Development Scale: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
by Anthony L. Vaccarino, PhD; Amir H. Kalali, MD; Pierre Blier, MD, PhD; Susan Gilbert Evans, MSc; Nina Engelhardt, PhD; Jane A. Foster, PhD; Benicio N. Frey, MD, PhD; John H. Greist, MD; Kenneth A. Kobak, PhD; Raymond W. Lam, MD, FRCPC; Glenda MacQueen, MD, PhD, FRCPC; Roumen Milev, MD, PhD, FRCPsych, FRCPC; Daniel J. […]
Research to Practice: The Effect of Early Life Stress on Adult Psychiatric Disorders
by Steven D. Targum, MD, and Charles B. Nemeroff, MD, PhD Dr. Targum is Scientific Director with CRF-Bracket in Boston, Massachusetts. Dr. Nemeroff is Professor of Psychiatry and Director of the Institute of Early Life Adversity Research at Dell Medical School, The University of Texas at Austin in Austin, Texas. Funding: No funding was provided. […]
Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report
by Michael M. Messer, MD, and Irina V. Haller, PhD, MS Dr. Messer is with Behavioral Health Department, Essentia Health, Duluth, MN, and Dr. Haller is with Essentia Institute of Rural Health, Essentia Health, Duluth, MN, USA. Innov Clin Neurosci. 2017;14(1–2):56–59. Funding: This research had no grant funding from any funding agency in the public, […]
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder
by Anthony L. Vaccarino, PhD; Kenneth R. Evans, PhD; Amir H. Kalali, MD; Sidney H. Kennedy, MD, FRCPC; Nina Engelhardt, PhD; Benico N. Frey, MD, MSc, PhD; John H. Greist, MD; Kenneth A. Kobak, PhD; Raymond W. Lam, MD, FRCPC; Glenda MacQueen, MD, PhD, FRCPC; Roumen Milev, MD, PhD, FRCPC, FRCPsych; Franca M. Placenza, PhD; Arun […]
Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma van Eijndhoven, MS, MA; Clement Francois, PhD; Crystal Henderson, PharmD, BCPP; and Leslie Citrome, MD, MPH Dr. MacEwan and Ms. van Eijndhoven are with Precision Health Economics in Los Angeles, California, USA; Dr. Seabury is with the University […]
The Impact of Spirituality Before and After Treatment of Major Depressive Disorder
by Eric Peselow, MD; Sarah Pi, BS; Enrique Lopez, PsyD; André Besada, BS; and Waguih William IsHak, MD, FAPA Dr. Peselow is from the Richmond University Medical Center and Freedom From Fear, Staten Island, New York; Ms. Pi, Dr. Lopez, Mr. Besada, and Dr. IsHak are from Cedars-Sinai Medical Center, Los Angeles, California. Innov Clin […]
Identification and Treatment of Antidepressant Tachyphylaxis
by Steven D. Targum, MD Dr. Targum is with Clintara, LLC, Boston, Massachusetts. Innov Clin Neurosci. 2014;11(3–4):24–28
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40–120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder
by Thomas Shiovitz, MD; William M. Greenberg, MD; Changzheng Chen, PhD; Giovanna Forero, MA; and Carl P. Gommoll, MS Dr. Shiovitz with the California Neuroscience Research Medical Group Inc, Sherman Oaks, California; and Dr. Greenberg, Mr. Chen, Ms. Forero, and Mr. Gommoll are from Forest Research Institute, Jersey City, New Jersey. Innov Clin Neurosci. 2014;11(1–2):10–22
The Bereavement Exclusion and DSM-5: An Update and Commentary
by Ronald W. Pies MD Dr. Pies is Professor of Psychiatry at SUNY Upstate Medical University, Syracuse, New York, and Clinical Professor of Psychiatry at Tufts University School of Medicine in Boston. Innov Clin Neurosci. 2014;11(7–8):19–22
Continue Reading